CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Par Health USA, LLC recalls Buprenorphine HCl

Read the official FDA notice

Published
24 Jun 2026
Units affected
46,334 units
Agency
FDA
Country
United States

The hazard

Crystallization; identified as Buprenorphine free base

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Buprenorphine HCl, CIII, Injection, 0.3 mg/mL, 5 x 1 mL Single Dose Vials per Carton, Rx Only, For Intramuscular or Intravenous use, Manufactured for: Endo USA, Malvern, PA 19355, NDC 42023-179-05

Brand / company
Par Health USA, LLC
Codes / lots
Lot #: 82886, exp 09/30/2026; 89646, exp 05/31/2027
Distribution
Nationwide in the USA.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 24 Jun 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.